MXPA01004227A - Method for producing 4- [(2',5'- diamino- 6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2- enylmethanols - Google Patents

Method for producing 4- [(2',5'- diamino- 6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2- enylmethanols

Info

Publication number
MXPA01004227A
MXPA01004227A MXPA/A/2001/004227A MXPA01004227A MXPA01004227A MX PA01004227 A MXPA01004227 A MX PA01004227A MX PA01004227 A MXPA01004227 A MX PA01004227A MX PA01004227 A MXPA01004227 A MX PA01004227A
Authority
MX
Mexico
Prior art keywords
diamino
amino
cyclopent
enylmethanols
general formula
Prior art date
Application number
MXPA/A/2001/004227A
Other languages
Spanish (es)
Inventor
Walter Brieden
Elie Saikali
Original Assignee
Lonza Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Group filed Critical Lonza Group
Publication of MXPA01004227A publication Critical patent/MXPA01004227A/en

Links

Abstract

The invention relates to a novel method for producing 4- [(2',5'-diamino- 6'-halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols of general formula (I), wherein X represents a halogen atom. According to the inventive method, a 2,5-diamino-4,6-halopyrimidine of general formula (II), wherein X has the aforementioned meaning, is reacted with a 4- aminocyclopent-2- enylmethanol of formula (III) or with a salt thereof in the presence of a base in a polar protic solvent.

Description

- PROCEDURE FOR THE PREPARATION OF 4- [(2 ', 5' -DIAMINO-6 '-HALOPIRIMID N-4' -IL) AMINO] -CICLOPENT-2-ENYLENETHOLES FIELD OF THE INVENTION The present invention relates to a new process for the preparation of 4- [(2 ', 5' -diamino-6 '-halopyrimidin-4' -yl) amino] cyclopent-2-enylmetañóles of the general formula 2 BACKGROUND OF THE INVENTION / 4- [(2 5'-Diamino-6'-halopyrimidin-1-yl) amino] cyclopent-2-enylmethanols are important intermediates for the preparation of antiviral nucleotide derivatives (WO 91/01310) . The 3-step synthesis of 4- [(2 J 5 '-diamino-6' -halo? Irimidin-1-yl) amino] cyclopent-2-enylmethanols from 4-acetamidocyclopent-2-enylmethanol is known by means of reaction with 2-amino-4,6-dichloropyrimidine in butanol with diisopropylethylamine as the base. For this first the [(2"-amino-6 '-chloropyridimin-4" -l) amino] cyclopent-2-enylmethanol is formed, which then in a later stage is transformed by means of diazotization, in the corresponding amine , which is then hydrolysed to the final product (J. Chem. Soc. Perkin, Trans., 1, 1992) This procedure has the disadvantage that it is expensive and that the desired final product is only obtained with a moderate yield. OF THE INVENTION The task of the present invention is to present a 1-step procedure, and therefore more economical for the preparation of 4- [(2'-5'-diamino-6 '-halopyrimidin-4'-yl) ) amino] -cyclopent-2-enylmethanols, in which the desired products are obtained in good yields DESCRIPTION OF THE INVENTION That task is solved with the process according to claim 1. Surprisingly it was found that when instead of 2- amino-, 6-dichloropyrimidine as starting material, a 2, 5-dia is used mino-, 6-dihalopyrimidine of the general formula H, N (II) and this is reacted in the presence of a base in a polar protic solvent with a 4-aminociclopent-2-enylmethanol of the formula or with a salt thereof, the desired final product of the general formula is obtained in a much more economical way and with a good performance. The substituent X means a halogen atom such as F, Cl, Br or I. 2, 5-diamino-, 6-dihalopyrimidine, as well as 2,5-diamino-4,6-dichloropyrimidine can be prepared according to EP-A-0 864 326. As 4-aminocilopent-2-enylmethanols, compounds can be used. both racemic and also optically active such as (1R, 4S) -, (1D, 4R) -, (1R, 4R) -, or (ls, 4s) -4-aminociclopent-2-enylmethanols. Suitable salts of these are the acid addition salts, especially the hydrohalogenide salts, for example the hydrochlorides and the bromohydrates. The 4-aminocyclopent-2-enylmethanols, especially the enantiomers (IR, 4S) - or (1S, 4R), can be prepared according to WO 97/45529. Advantageously, the reaction is carried out in the presence of an alkali metal or alkaline earth metal carbonate, an alkali metal or alkaline earth metal hydrocarbonate or in the presence of nitrogen bases, such as, for example, tertiary amines, as the base. As the alkali metal carbonate or alkali metal hydrocarbonate, sodium or potassium carbonate or sodium or potassium hydrocarbonate can be used. As the alkaline earth metal carbonate or alkaline earth metal hydrocarbonate, calcium or magnesium carbonate or calcium hydrocarbonate may be used. Suitable tertiary amines are, for example, triethylamine and diisopropylethylamine. Preferably, the reaction is carried out in the presence of an alkali metal hydrocarbonate such as sodium hydrocarbonate or in the presence of a tereamine, such as diisopropylethylamine. The base is advantageously used in an excess relative to 2, 5-diamino-4,6-dihalopyrimidine, preferably 1 to 4 moles of base are used per mole of 2,5-diamino-4,6-dihalopyrimidine. As the polar protic solvent, alcohols with 1 to 4 carbon atoms, such as methanol, are particularly suitable., ethanol, propanol and its isomers and butanol and its isomers. Advantageously, the reaction is carried out at a temperature of 20 ° C up to the reflux temperature of the corresponding solvent, preferably 50 ° C up to the reflux temperature. Advantageously, 4-aminociclopent-2-enylmethanol and 2,5-diamino-4,6-dihalopyrimidine are used equimolarly. After a reaction time of 2 to 20 hours the final products can then be obtained according to formula I, preferably (lS, 4R) -4- [(2 5'-diamino-6 '-halopyrimidin-4'I) ) amino] cyclopent-2-enylmethanol, by means of the usual processing methods. EXAMPLES Example 1 Preparation of 4- [(2 ', 5'-diamino-6'-chloropyrimidin-4'-yl) amino] cyclopent-2-enylmethanol in the presence of sodium hydrocarbonate Hydrochloride of (SS, 4R) -4 -aminocyclopent-2-enylmethanol (0.14 mol, 23.25 g), ethanol (3 mol, 138.12 g 176 ml), 2,5-diamino-4,6-dichloropyrimidine (0.14 mol, 25 g) and sodium hydrocarbonate (0.34 mol) , 28.68 g) were introduced to a dry reactor. This mixture was heated to reflux temperature (about 80 ° C) for 16 hours. The transformation rate was tested according to TLC (thin layer chrography) with 13/1 methylene chloride: methanol as eluent. The reaction mixture was cooled to room temperature and stirred for 45 minutes. The salts were removed by filtration and the filter cake was washed twice with ethanol (0.86 mol, 39.5 g, 50 ml). After 2/3 of the organic phase had been removed by distillation, it was added dropwise (150 ml) of hexane. The suspension was cooled to 10 ° C. After filtering, it is dried in vacuo at 50 ° C. 21.5 g (0.08 mol) of final product were obtained, corresponding to a yield of 60%. Example 2 Preparation of 4 [(2 J 5 '-diamino-6' -chloropyrimidin-4'-yl) amino] cyclo? Ent-2-enylmethanol in the presence of diisopropylethylamine Hydrochloride of (SS, 4R) -4-aminociclopent -2-enyl-methanol (0.14 mol, 23.18 g), butanol (1.26 mol, 93.39 g, 115.3 ml), 2,5-diamino-4,6-dichloropyrimidine (0.14 mol, 25.67 g) and diisopropylethylamine (0.29 g) mol, 37.09 g, 49.99 ml) are introduced into a dry reactor. This mixture was heated overnight at reflux temperature (about 115 ° C). The reaction rate was tested according to TLC with 13/1 methylene chloride: methanol as eluent. The reaction mixture was cooled to room temperature. Then water was added and then extracted twice with ethyl acetate. The organic phase was washed twice with water, and then the organic phase was filtered through Celite. After 2/3 of the organic phase was separated by vacuum distillation, hexane was added dropwise. The suspension was cooled to below 10 ° C. After filtering, it was dried under vacuum at 50 ° C. 21.47 g (0.08 mol) of final product were obtained, corresponding to a yield of 60%.

Claims (3)

  1. NOVELTY OF THE INVENTION Having described the invention as above, the content of the following is claimed as property: CLAIMS 1.- Procedure for the preparation of 4- [(2'-5'-diamino-6 '-halopyrimidin-4' -il amino) -cyclopent-2-enylmethanols of the general formula wherein X means a halogen atom, characterized in that to form the final product of the general formula I, a 2,5-diamino-4,6-dihalogenopyrimidine of the general formula is reacted wherein X has the given meaning, with a 4-aminocylopent-2-enylmethanol of the formula or a salt thereof, in the presence of an alkali metal or alkaline earth metal carbonate or in the presence of an alkali metal or alkaline earth metal hydrocarbonate a protic polar solvent.
  2. 2. Process according to claim 1, characterized in that an alcohol with 1 to 4 carbon atoms is used as the protic polar solvent.
  3. 3. Process according to claim 1 or 2, characterized in that the reaction is carried out at a temperature comprised between 20 ° C at the reflux temperature of the corresponding solvent.
MXPA/A/2001/004227A 1998-10-30 2001-04-27 Method for producing 4- [(2',5'- diamino- 6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2- enylmethanols MXPA01004227A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98120529.7 1998-10-30
US60/146,105 1999-07-29

Publications (1)

Publication Number Publication Date
MXPA01004227A true MXPA01004227A (en) 2002-05-09

Family

ID=

Similar Documents

Publication Publication Date Title
RU2394026C2 (en) Method for optical separation of amlodipine
EP0928787B1 (en) Process for the preparation of 3-amino-pyrrolidine derivatives
EP4126904A1 (en) Preparation of cyclosporin derivatives
KR20040007978A (en) A process for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
KR100649175B1 (en) Method for producing enantiomer-free n-methyl-n-[1s-1-phenyl-2-3s-3-hydroxypyrrolidine-1-ylethyl]-2,2-diphenyl acetamide
JP4457496B2 (en) Process for producing 4-[(2 ', 5'-diamino-6'-halogenpyrimidin-4'-yl) amino] cyclopent-2-enylmethanol
MXPA01004227A (en) Method for producing 4- [(2',5'- diamino- 6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2- enylmethanols
US8030486B2 (en) Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation
KR20210010487A (en) Intermediates and methods for the preparation of linagliptin and salts thereof
KR100606625B1 (en) Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-ylamino]-cyclopent-2-enylmethanols
EP0969002B1 (en) L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethyl-piperidine compound and process for preparing the same
KR101299720B1 (en) A novel process for preparing 3-amino-5-fluoro-4-dialkoxypetanoic acid ester
EP1188744B1 (en) Process for producing optically active 1H-3-aminopyrrolidine and derivatives thereof
KR100850558B1 (en) Process for preparing useful in synthesis of atorvastatin
HU223138B1 (en) Novel process for producing alkyl-4,6,7,8,9,9a-hexahydro-2h,3h-pyrido[1,2-a]pyrazin-1-on-7-carboxylate esters
SK282272B6 (en) Glutaric acid derivatives and method for the preparation thereof and intermediate product of said method
CZ135397A3 (en) Efficient and highly enantiomer selective process for preparing enantiomer pure cyclopentane-{beta}- amino acids
EP2938595B1 (en) Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus
JP2002316977A (en) Method for producing optically active 1h-3- aminopyrrolidine compound
KR20030057222A (en) Preparation method of cinnamic acid derivative
JPS62273950A (en) 4-alkoxy-3-pyrroline-2-one-1-yl-acetic acid amide, manufacture and use
KR20060125218A (en) The optical resolution method of benzoxazine derivative